Structure of BAY-876
CAS No.: 1799753-84-6
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
BAY-876 is a selective inhibitor of GLUT1 with IC50 of 0.002 μM with good metabolic stability.
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 1799753-84-6 |
Formula : | C24H16F4N6O2 |
M.W : | 496.42 |
SMILES Code : | O=C(C1=NC2=CC(F)=CC=C2C(C(NC3=C(C)N(CC4=CC=C(C#N)C=C4)N=C3C(F)(F)F)=O)=C1)N |
MDL No. : | MFCD30377201 |
InChI Key : | BKLJDIJJOOQUFG-UHFFFAOYSA-N |
Pubchem ID : | 118191391 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302 |
Precautionary Statements: | P280-P305+P351+P338 |
Target |
|
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
HC11 cells | 100 nM | 24 hours | No obvious negative impact on GLUT1-normal cell populations | PMC10622423 |
MDA-MB-468 | 3 µM | 72 hours | No significant changes in cell cycle observed | PMC7442809 |
MDA-MB-436 | 3 µM | 72 hours | No significant changes in cell cycle observed | PMC7442809 |
DU145 cells | 25 µM, 12 µM, 6 µM, 3 µM, 1.5 µM, 0.7 µM | 0, 24, 48, 72 hours | To evaluate the inhibitory effect of BAY-876 on the viability of prostate cancer cells. Results showed that as the concentration of BAY-876 increased, cell activity gradually weakened. The IC50 of PC-3 at 24 h was 0.70 µM, and that of DU145 was 2.19 µM. | PMC11515740 |
PC-3 cells | 25 µM, 12 µM, 6 µM, 3 µM, 1.5 µM, 0.7 µM | 0, 24, 48, 72 hours | To evaluate the inhibitory effect of BAY-876 on the viability of prostate cancer cells. Results showed that as the concentration of BAY-876 increased, cell activity gradually weakened. The IC50 of PC-3 at 24 h was 0.70 µM, and that of DU145 was 2.19 µM. | PMC11515740 |
HaCaT cells | 1 mM | 2 hours | To evaluate the inhibitory effect of BAY-876 on Glu-4-ZnPc uptake in HaCaT cells | PMC11207564 |
Primary Gingival Keratinocytes | 10 nM to 100 µM | 24 hours | BAY-876 inhibited glucose uptake in primary gingival keratinocytes and reduced cell viability. | PMC11282258 |
FaDu | 10 nM to 100 µM | 24 hours | BAY-876 inhibited glucose uptake in FaDu cells, reduced cell viability and metabolism, and induced apoptosis. | PMC11282258 |
RPMI2650 | 10 nM to 100 µM | 24 hours | BAY-876 inhibited glucose uptake in RPMI2650 cells, reduced cell viability and metabolism, and induced apoptosis. | PMC11282258 |
SCC47 | 10 nM to 100 µM | 24 hours | BAY-876 inhibited glucose uptake in SCC47 cells, reduced cell viability and metabolism, and induced apoptosis. | PMC11282258 |
4T1 cells | 100 nM | 24 hours | Inhibited glycolysis activity in 4T1 cells, reduced PD-L1 glycosylation levels, and enhanced the binding affinity of aptPD-L1 to PD-L1 | PMC10622423 |
HCT116 cells | 1 μM | 24 hours | BAY-876 inhibited the proliferation of HCT116 cells with an IC50 of 0.1–0.2 µmol/L. | PMC11010912 |
LS174T cells | 1 μM | 24 hours | BAY-876 inhibited the proliferation of LS174T cells with an IC50 of 0.1–0.2 µmol/L. | PMC11010912 |
HEK293 cells | 0.05 μM, 1 μM, 5 μM | 30 minutes | To assess the inhibitory effect of BAY-876 on glucose uptake mediated by GLUT1-6 and GLUT10. Results showed BAY-876 inhibited glucose uptake via GLUT1, GLUT3, GLUT4, GLUT6, and GLUT10, but not GLUT2. | PMC9776291 |
HEK293 cells | 0.05 μM, 1 μM, 5 μM | 30 minutes | To assess the ability of BAY-876 to inhibit hexose uptake via facilitative glucose transporters. Results showed BAY-876 inhibited glucose uptake via GLUT1, GLUT3, GLUT4, GLUT6, and GLUT10, but not GLUT2. | PMC9776291 |
HepG2 cells | 1 μM | 48 hours | BAY-876 significantly inhibited the expression of glycogenesis-related genes GBE1, GYS1, UGP2, and glycogenolysis-related gene PYGM | PMC10339511 |
Huh7 cells | 1 μM | 48 hours | BAY-876 significantly inhibited the expression of glycogenesis-related genes GBE1, GYS1, UGP2, and glycogenolysis-related gene PYGM | PMC10339511 |
Pt2377 | 25-400 nM | 5 days | BAY-876 inhibited the proliferation of Pt2377 cells. | PMC9081236 |
LS174T | 25-400 nM | 5 days | BAY-876 inhibited the proliferation of LS174T cells. | PMC9081236 |
Hs 578T | 3 µM | 72 hours | Inhibited cell growth and proliferation, increased cell cycle arrest and apoptosis | PMC7442809 |
HCC1806 | 3 µM | 72 hours | Inhibited cell growth and proliferation, increased cell cycle arrest and apoptosis | PMC7442809 |
UMRC6 cells | 2 μM | Measure cell death, results showed BAY-876 significantly increased death in SLC7A11-high cells | PMC7194135 | |
786-O cells | 2 μM | Measure glucose uptake levels and NADP+/NADPH ratios, results showed BAY-876 significantly inhibited glucose uptake and increased NADP+/NADPH ratios | PMC7194135 | |
GL261 cells | 2 nM | 72 hours | Inhibit GLUT1 expression and reduce lactate excretion | PMC11095231 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
Balb/c mice | 4T1 tumor model | Intravenous injection | 0.05 µg/mL/g | Once every two days for 21 days | Significantly inhibited tumor growth, reduced lactic acid and UDP-GlcNAc levels in the tumor microenvironment, and enhanced anti-tumor immune responses | PMC10622423 |
Mice | Muscle-specific GLUT1 knockout mice | In vitro muscle incubation | 0.05 μM, 1 μM, 5 μM | 60 minutes | To evaluate the effect of BAY-876 on basal and overload-stimulated muscle glucose uptake. Results showed that low-dose BAY-876 (0.05 μM) completely impaired overload-stimulated glucose uptake but did not affect basal uptake. | PMC9776291 |
Mice | Muscle-specific GLUT1 knockout (mGLUT1KO) mice | Ex vivo muscle incubation | 0.05 μM, 1 μM, 5 μM | 60 minutes | To assess the effect of BAY-876 on basal and overload-stimulated muscle glucose uptake. Results showed that a low dose of BAY-876 (0.05 μM) completely impaired overload-stimulated but not basal glucose uptake. | PMC9776291 |
C57BL/6 mice | STZ-induced hyperglycemic model | Intravenous injection | 1.0 mg/kg | Daily injections for 16 days | BAY-876 significantly reduced STZ-induced astrocyte proliferation but had no effect on microglia numbers | PMC11131277 |
Balb/c mice | 4T1 breast tumor xenograft model | Tail vein injection | 10 mg/kg | Single dose, monitored for 14 days | Evaluate the in vivo antitumor efficacy and biodistribution of CFMB, showing significant tumor growth suppression without systemic toxicity. | PMC11187878 |
Mice | NCI-H226 xenograft tumors | Intraperitoneal injection | 100 mg/kg | Every two days | Evaluate the therapeutic effect of GLUT inhibitors on SLC7A11-high tumors, results showed BAY-876 significantly suppressed tumor growth | PMC7194135 |
Mice | PDX model | Oral | 2 mg/kg daily | Once daily for 30 days | Impaired tumor growth with no significant loss of body weight | PMC7442809 |
C57BL/6J mice | Subcutaneous GBM model | Subcutaneous injection | 2 nM | 21 days | Inhibit lactate excretion and delay tumor growth | PMC11095231 |
Nude mice | HCC xenograft model | Gavage | 2.5 mg/kg | Every 3 days for 28 days | BAY-876 significantly inhibited BMP4-induced subcutaneous tumor growth and glycogen accumulation | PMC10339511 |
RAG1−/−γc− mice | LS174T cell xenograft model | Oral administration | 3 mg/kg/day | Once daily for 12 days | BAY-876 significantly inhibited tumor growth in the LS174T cell xenograft model. | PMC11010912 |
SCID mice | LS174T xenograft model | Oral (BAY-876), Intraperitoneal (DBI-1) | 3 mg/kg/day (BAY-876), 40 mg/kg/day (DBI-1) | Once daily for 12 days | BAY-876 and DBI-1 alone or in combination inhibited tumor growth, with combination therapy being more effective than either compound alone. | PMC9081236 |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.01mL 0.40mL 0.20mL |
10.07mL 2.01mL 1.01mL |
20.14mL 4.03mL 2.01mL |
Tags: BAY-876 | BAY876 | BAY 876 | GLUT | Glucose transporter | GLUT1 inhibitor | glycolytic metabolism | glucose transport | GLUT2 inhibitor | GLUT3 inhibitor | GLUT4 inhibitor | 1799753-84-6
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL